Clinicaltrials.gov info:Does anyone know why 2 of these studies...

  1. 1,072 Posts.
    lightbulb Created with Sketch. 126

    Clinicaltrials.gov info:

    Does anyone know why 2 of these studies on the gov site say still recruiting?

    http://clinicaltrials.gov/ct2/results?term=invion&Search=Search

    ...


    Recruiting Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
    Condition: Mild Persistent Asthma, Uncomplicated
    Interventions: Drug: Nadolol; Drug: Placebo

    Not yet recruiting Efficacy and Safety of ?eta-adrenoceptor Inverse Agonist, Nadolol, In Smoking Cessation of Patients With Pre-existing COPD
    Condition: Smoking Cessation
    Interventions: Drug: Nadolol; Drug: Placebo

    ...

    Recruiting Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With SLE.
    Condition: Lupus Erythematosus, Systemic
    Interventions: Biological: Ala-Cpn10; Drug: Placebo
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.9¢
Change
0.003(3.13%)
Mkt cap ! $8.456M
Open High Low Value Volume
9.6¢ 9.9¢ 9.6¢ $4.743K 48.59K

Buyers (Bids)

No. Vol. Price($)
2 73355 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 49735 1
View Market Depth
Last trade - 15.03pm 01/08/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.